Welcome to
Издательство Атмосфера

· Журналы
· Книги
· О проекте

·Электронные версии книг издательства “Атмосфера” поступили в продажу

Издательство “Атмосфера” идет в ногу со временем и открывает на своем сайте раздел электронных версий своих книг. Теперь вы можете приобрести не только традиционную бумажную книгу в картонном переплете, но и .pdf-файл, снабженный гиперссылками на каждую главу издания. В электронной версии проще отыскать рисунок и таблицу. Чтобы обратиться к ним, достаточно нажать на ссылку на каждый из них. Исчезла зависимость от тиража – вы можете приобрести даже те бестселлеры, тираж которых уже разошелся, такие как “Саркоидоз” или “Заболевания органов дыхания при беременности”. Упростилось получение вами книг – в течение двух рабочих дней после оплаты требуемые файлы придут на ваш e-mail. Ну и наконец, цена – электронные версии наших книг гораздо дешевле, чем бумажные издания. Заказывайте электронные версии книг издательства “Атмосфера” на сайте, а также по телефону: (495) 730-63-51 и по e-mail: atm-press2012@yandex.ru


ИНТЕРНЕТ-МАГАЗИН
Издательство Атмосфера


Телефон издательства

  
Лечебное дело
2021 / N 3

Профилактика венозных тромбоэмболических осложнений у пациентов с ревматоидным артритом и системной красной волчанкой при проведении ортопедических операций
Т.М. Решетняк, В.Н. Амирджанова, М.А. Макаров

Список литературы

1. Pedersen AB, Sorensen HT, Mehnert F, Overgaard S, Johnsen SP. Risk factors for venous thromboembolism in patients undergoing total hip replacement and receiving routine thromboprophylaxis. The Journal of Bone and Joint Surgery. American Volume 2010 Sep;92(12):2156-64.
2. Clement ND, Breusch SJ, Biant LC. Lower limb joint replacement in rheumatoid arthritis. Journal of Orthopaedic Surgery and Research 2012 Jun;7:27.
3. Tanaka E, Saito A, Kamitsuji S, Yamada T, Nakajima A, Taniguchi A, Hara M, Tomatsu T, Yamanaka H, Kamatani N. Impact of shoulder, elbow, and knee joint involvement on assessment of rheumatoid arthritis using the American College of Rheumatology core data set. Arthritis & Rheumatism 2005 Dec;53(6):864-71.
4. Danoff JR, Moss G, Liabaud B, Geller JA. Total knee arthroplasty consideration in rheumatoid arthritis. Autoimmune Diseases 2013;2013:185340.
5. Garbarino LJ, Gold PA, Sodhi N, Anis HK, Ehiorobo JO, Boraiah S, Danoff JR, Rasquinha VJ, Higuera-Rueda CA, Mont MA. The effect of operative time on in-hospital length of stay in revision total knee arthroplasty. Annals of Translational Medicine 2019 Feb;7(4):66.
6. Lee JK, Choi СH. Total knee arthroplasty in rheumatoid arthritis. Knee Surgery & Related Research 2012 Mar;24(1):1-6.
7. Grennan DM, Gray J, Loudon J, Fear S. Methotrexate and early postoperative complications in patients with rheumatoid arthritis undergoing elective orthopaedic surgery. Annals of the Rheumatic Diseases 2001 Mar;60(3):214-7.
8. Sreekumar R, Gray J, Kay P, Grennan DM. Methotrexate and post operative complications in patients with rheumatoid arthritis undergoing elective orthopaedic surgery – a ten year follow-up. Acta Orthopaedica Belgica 2011 Dec;77(6):823-6.
9. Eid AS, Mohamed Nassar WA, Mohamed Fayyad TA. Total knee replacement with tibial tubercle osteotomy in rheumatoid patients with stiff knee. International Orthopaedics 2016 Nov;40(11):2289-93.
10. Howe CR, Gardner GC, Kadel NJ. Perioperative medication management for the patient with rheumatoid arthritis. The Journal of the American Academy of Orthopaedic Surgeons 2006 Sep;14(9):544-51.
11. Насонов Е.Л., Каратеев Д.Е. Применение генно-инженерных биологических препаратов для лечения ревматоидного артрита: общая характеристика (лекция). Научно-практическая ревматология 2013;51(2):163-9.
12. Hayashi M, Kojima T, Funahashi K, Kato D, Matsubara H, Shioura T, Kanayama Y, Hirano Y, Ishiguro N. Effect of total arthroplasty combined with anti-tumor necrosis factor agents in attenuating systemic disease activity in patients with rheumatoid arthritis. Modern Rheumatology 2012 Jun;22(3):363-9.
13. Sreekumar R, Gray J, Kay P, Grennan DM. Methotrexat and post operative complication in patients with rheumatoid arthritis undergoing elective orthopedic surgery – a ten-year follow-up. Acta Orthopaedic Belgica 2011 Dec;77(6):823-6.
14. Hayashi M, Kojima T, Funahashi K, Kato D, Matsubara H, Shioura T, Kanayama Y, Hirano Y, Ishiguro N. Effect of total arthroplasty combined with anti-tumor necrosis factor agents in attenuating systemic disease activity in patients with rheumatoid arthritis. Modern Rheumatology 2012 Jun;22(3):363-9.
15. Goodman SM, Springer B, Guyatt G, Abdel MP, Dasa V, George M, Gewurz-Singer O, Giles JT, Johnson B, Lee S, Mandl LA, Mont MA, Sculco P, Sporer S, Stryker L, Turgunbaev M, Brause B, Chen AF, Gililland J, Goodman M, Hurley-Rosenblatt A, Kirou K, Losina E, MacKenzie R, Michaud K, Mikuls T, Russell L, Sah A, Miller AS, Singh JA, Yates A. 2017 American College of Rheumatology/American Association of Hip and Knee Surgeons Guideline for the perioperative management of antirheumatic medication in patients with rheumatic diseases undergoing elective total hip or total knee arthroplasty. Arthritis Care & Research 2017 Aug;69(8):1111-24.
16. Sevitt S. Pathology and pathogenesis of deep vein thrombosis. In: Venous problems. Bergan J, Yao J, editors. Chicago: Year Book Medical Publishers; 1976.
17. Nicolaides A, Kakkar V, Renney J. Solia sinuses and stasis. The British Journal of Surgery 1970 Apr;57(4):307.
18. Nicolaides AN, Kakkar VV, Field ES, Fish P. Venous stasis and deep-vein thrombosis. The British Journal of Surgery 1972 Sep;59(9):713-7.
19. Clark C, Cotton L. Blood flow in deep veins of leg: recording technique and evaluation of method to increase flow during operation. The British Journal of Surgery 1968 Mar;55(3):211-4.
20. Lindström B, Ahlman H, Jonsson O, Stenqvist O. Influence of anaesthesia on blood flow to the calves during surgery. Acta Anaesthesiologica Scandinavica 1984 Apr;28(2):201-3.
21. Lindström B, Ahlman H, Jonsson O, Sivertsson R, Stenqvist O. Blood flow in the calves during surgery. Acta Chirurgica Scandinavica 1977;143(6):335-9.
22. Stamatakis JD, Kakkar VV, Sagar S, Lawrence D, Nairn D, Bentley PG. Femoral vein thrombosis and total hip replacement. BMJ 1977 Jul;2(6081):223-5.
23. Johnson R, Carmichael JH, Almond HG, Loynes RP. Deep venous thrombosis following Charnley arthroplasty. Clinical Orthopaedics and Related Research 1978 May;132:24-30.
24. Planes A, Vochelle N, Fagola M. Total hip replacement and deep vein thrombosis: a venographic and necropsy study. The Journal of Bone & Joint Surgery. British Volume 1990 Jan;72(1):9-13.
25. Gitel SN, Salvati EA, Wessler S, Robinson HJ Jr, Worth MH Jr. The effect of total hip replacement and general surgery on antithrombin III in relation to venous thrombosis. The Journal of Bone and Joint Surgery. American Volume 1979 Jul;61(5):653-6.
26. Eriksson BI, Eriksson E, Gyzander E, Teger-Nilsson AC, Risberg B. Thrombosis after hip replacement. Relationship to the fibrinolytic system. Acta Orthopaedica Scandinavica 1989 Apr;60(2):159-63.
27. Kluft C, Verheijen JH, Jie AF, Rijken DC, Preston FE, Sue-Ling HM, Jespersen J, Aasen AO. The postoperative fibrinolytic shutdown: a rapidly reverting acute phase pattern for the fast-acting inhibitor of tissue-type plasminogen activator after trauma. Scandinavian Journal of Clinical and Laboratory Investigation 1985 Nov;45(7):605-10.
28. D’Angelo A, Kluft C, Verheijen JH, Rijken DC, Mozzi E, Mannucci PM. Fibrinolytic shut-down after surgery: impairment of the balance between tissue-type plasminogen activator and its specific inhibitor. European Journal of Clinical Investigation 1985 Dec;15(6):308-12.
29. Geerts WH, Bergqvist D, Pineo GF, Heit JA, Samama CM, Lassen MR, Colwell CW. Prevention of venous thromboembolism: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition). Chest 2008 Jun;133(6 Suppl):381S-453S.
30. Caprini J. Risk assessment as a guide for the prevention of the many faces of venous thromboembolism. The American Journal of Surgery 2010 Jan;199(1 Suppl):S3-10.
31. Bahl V, Hu HM, Henke PK, Wakefield TW, Campbell DA Jr, Caprini JA. A validation study of a retrospective venous thromboembolism risk scoring method. Annals of Surgery 2010 Feb;251(2):344-50.
32. Ассоциация флебологов России; Ассоциация сердечно-сосудистых хирургов России; Всероссийское общество хирургов; Российское научное медицинское общество терапевтов; Общество специалистов по неотложной кардиологии. Российские клинические рекомендации по диагностике, лечению и профилактике венозных тромбоэмболических осложнений (ВТЭО). Флебология. Выпуск 2 2015;9(4):6-52.
33. Falck-Ytter Y, Francis CW, Johanson NA, Curley C, Dahl OE, Schulman S, Ortel TL, Pauker SG, Colwell CW Jr. Prevention of VTE in orthopedic surgery patients: antithrombotic therapy and prevention of thrombosis. 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 2012 Feb;141(2 Suppl):e278S-325S.
34. Hull RD, Pineo GF, Stein PD, Mah AF, MacIsaac SM, Dahl OE, Butcher M, Brant RF, Ghali WA, Bergqvist D, Raskob GE. Extended out-of-hospital low-molecular-weight heparin prophylaxis against deep venous thrombosis in patients after elective hip arthroplasty: a systematic review. Annals of Internal Medicine 2001 Nov;135(10):858-69.
35. Eikelboom JW, Quinlan DJ, Douketis JD. Extended-duration prophylaxis against venous thromboembolism after total hip or knee replacement: a meta-analysis of the randomized trials. The Lancet 2001 Jul;358(9275):9-15.
36. Prandoni P, Bruchi O, Sabbion P, Tanduo C, Scudeller A, Sardella C, Errigo G, Pietrobelli F, Maso G, Girolami A. Prolonged thromboprophylaxis with oral anticoagulants after total hip arthroplasty: a prospective controlled randomized study. Archives of Internal Medicine 2002 Sep;162(17):1966-71.
37. Kim JS. Deep vein thrombosis prophylaxis after total hip Arthroplasty in Asian patients. Hip & Pelvis 2018 Dec;30(4):197-201.
38. Ettema HB, Hoppener MR, Veeger NJGM, Büller HR, van der Meer J. Low incidence of venographically detected deep vein thrombosis after knee arthroscopy without thromboprophylaxis: a prospective cohort study. Journal of Thrombosis and Haemostasis 2006 Jun;4(6):1411-4.
39. Hoppener MR, Ettema HB, Henny CR, Verheyen CCPM, Büller HR. Low incidence of deep vein thrombosis after knee arthroscopy without thromboprophy-laxis: a prospective cohort study of 335 patients. Acta Orthopoedica 2006 Oct;77(5):767-71.
40. Kahn SR, Shivakumar S. What’s new in VTE risk and prevention in orthopedic surgery. Research and Practice in Thrombosis and Haemostasis 2020 Mar;4(3):366-76.
41. Ilahi OA. Deep venous thrombosis after knee arthroscopy: a meta-analysis. Arthroscopy: the Journal of Arthroscopic & Related Surgery 2005 Jun;21(6):727-30.
42. Camporese G, Bernardi E, Prandoni P, Noventa F, Verlato F, Simioni P, Ntita K, Salmistraro G, Frangos C, Rossi F, Cordova R, Franz F, Zucchetta P, Kontothanassis D, Andreozzi GM; KANT (Knee Arthroscopy Nadroparin Thromboprophylaxis) Study Group. Low-molecular-weight heparin versus compression stockings for thromboprophylaxis after knee arthroscopy: a randomized trial. Annals of Internal Medicine 2008 Jul;149(2):73-82.
43. Wirth T, Schneider B, Misselwitz F, Lomb M, Tüylü H, Egbring R, Griss P. Prevention of venous thromboembolism after knee arthroscopy with low-molecular weight heparin (reviparin): results of a randomized controlled trial. Arthroscopy 2001 Apr;17(4):393-9.
44. Michot M, Conen D, Holtz D, Erni D, Zumstein MD, Ruflin GB, Renner N. Prevention of deep-vein thrombosis in ambulatory arthroscopic knee surgery: a randomized trial of prophylaxis with low-molecular weight heparin. Arthroscopy 2002 Mar;18(3):257-63.
45. Ramos J, Perrotta C, Badariotti G, Berenstein G. Interventions for preventing venous thromboembolism in adults undergoing knee arthroscopy (Review). Cochrane Database of Systematic Reviews 2008 Oct 8;(4):CD005259.
46. Galanis T, Thomson L, Palladino M, Merli G. New oral anticoagulants. Journal of Thrombosis and Thrombolysis 2011 Apr;31(3):310-20.
47. Raghavan N, Frost CE, Yu Z, He K, Zhang H, Humphreys WG, Pinto D, Chen S, Bonacorsi S, Wong PC, Zhang D. Apixaban metabolism and pharmacokinetics after oral administration to humans. Drug Metabolism & Disposition 2009 Jan;37(1):74-81.
48. Lassen MR, Raskob GE, Gallus A, Pineo G, Chen D, Portman RJ. Apixaban or enoxaparin for thromboprophylaxis after knee replacement. The New England Journal of Medicine 2009 Aug;361(6):594-604.
49. Lassen MR, Raskob GE, Gallus A, Pineo G, Chen D, Hornick P; ADVANCE-2 Investigators. Apixaban versus enoxaparin for thromboprophylaxis after knee replacement (ADVANCE-2): a randomised double-blind trial. The Lancet 2010 Mar;375(9717):807-15.
50. Lassen MR, Gallus A, Raskob GE, Pineo G, Chen D, Ramirez LM; ADVANCE-3 Investigators. Apixaban versus enoxaparin for thromboprophylaxis after hip replacement. The New England Journal of Medicine 2010 Dec;363(26):2487-98.
51. Eriksson BI, Borris LC, Friedman RJ, Haas S, Huisman MV, Kakkar AK, Bandel TJ, Beckmann H, Muehlhofer E, Misselwitz F, Geerts W; RECORD1 Study Group. Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplasty. The New England Journal of Medicine 2008 Jun;358(26):2765-75.
52. Lassen MR, Ageno W, Borris LC, Lieberman JR, Rosencher N, Bandel TJ, Misselwitz F, Turpie AG. Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty. The New England Journal of Medicine 2008 Jun;358(26):2776-86.
53. Kakkar AK, Brenner B, Dahl OE, Eriksson ВI, Mouret P, Muntz J, Soglian AG, Pap AF, Misselwitz F, Haas S; RECORD2 Investigators. Extended duration rivaroxaban versus short-term enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty: a double-blind, randomised controlled trial. The Lancet 2008 Jul;372(9632):31-9.
54. Turpie AG, Lassen MR, Davidson BL, Bauer KA, Gent M, Kwong LM, Cushner FD, Lotke PA, Berkowitz SD, Bandel TJ, Benson A, Misselwitz F, Fisher WD; RECORD4 Investigators. Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty (RECORD4): a randomised trial. The Lancet 2009 May;373(9676):1673-80.
55. Eriksson BI, Dahl OE, Rosencher N, Kurth AA, van Dijk CN, Frostick SP, Kalebo P, Christiansen AV, Hantel S, Hettiarachchi R, Schnee J, Büller HR; RE-MODEL Study Group. Oral dabigatran etexilate vs. subcutaneous enoxaparin for the prevention of venous thromboembolism after total knee replacement: the RE-MODEL randomized trial. Journal of Thrombosis and Haemostasis 2007 Nov;5(11):2178-85.
56. Eriksson BI, Dahl OE, Rosencher N, Kurth AA, van Dijk CN, Frostick SP, Prins MH, Hettiarachchi R, Hantel S, Schnee J, Buller HR. Dabigatran etexilate versus enoxaparin for prevention of venous thromboembolism after total hip replacement: a randomised, double-blind, non-inferiority trial. The Lancet 2007 Sep;370(9591):949-56.
57. Eriksson BI, Dahl OE, Huo MH, Kurth AA, Hantel S, Hermansson K, Schnee JM, Friedman RJ; RE-NOVATE II Study Group. Oral dabigatran versus enoxaparin for thromboprophylaxis after primary total hip arthroplasty (RE-NOVATE II*). A randomised, double-blind, non-inferiority trial. Thrombosis and Haemostasis 2011 Apr;105(4):721-9.
58. RE-MOBILIZE Writing Committee; Ginsberg JS, Davidson BL, Comp PC, Francis CW, Friedman RJ, Huo MH, Lieberman JR, Muntz JE, Raskob GE, Clements ML, Hantel S, Schnee JM, Caprini JA. Oral thrombin inhibitor dabigatran etexilate vs North American enoxaparin regimen for prevention of venous thromboembolism after knee arthroplasty surgery. The Journal of Arthroplasty 2009 Jan;24(1):1-9.
59. Venker BT, Ganti BR, Lin H, Lee ED, Nunley RM, Gage BF. Safety and efficacy of new anticoagulants for the prevention of venous thromboembolism after hip and knee arthroplasty: a meta-analysis. The Journal of Arthroplasty 2017 Feb;32(2):645-52.
60. Ferro JM, Coutinho JM, Dentali F, Kobayashi A, Alasheev A, Canhão P, Karpov D, Nagel S, Posthuma L, Roriz JM, Caria J, Frässdorf M, Huisman H, Reilly P, Diener HC; RE-SPECT CVT Study Group. Safety and efficacy of dabigatran etexilate vs dose-adjusted warfarin in patients with cerebral venous thrombosis: a randomized clinical trial. JAMA Neurology 2019 Dec;76(12):1457-65.
61. Samoš M, Stančiaková L, Ivanková J, Staško J, Kovář F, Dobrotová M, Galajda P, Kubisz P, Mokáň M. Monitoring of dabigatran therapy using Hemoclot(®) Thrombin Inhibitor assay in patients with atrial fibrillation. Journal of Thrombosis and Thrombolysis 2015 Jan;39(1):95-100.
62. Poli S, Härtig F, Spencer C, Ebner M, Birschmann I, Kuhn J, Faix S, Ziemann U, Häring HU, Lehmann R, Peter A, Hörber S. Diagnostic accuracy of a novel chromogenic direct thrombin inhibitor assay: clinical experiences for dabigatran monitoring. Thrombosis and Haemostasis 2017 Dec;117(12):2369-75.
63. Cohen AT, Hamilton M, Mitchell SA, Phatak H, Liu X, Bird A, Tushabe D, Batson S. Comparison of the novel oral anticoagulants apixaban, dabigatran, edoxaban, and rivaroxaban in the initial and long-term treatment and prevention of venous thromboembolism: systematic review and network meta-analysis. PLoS One 2015 Dec;10(12):e0144856.

References

1. Pedersen AB, Sorensen HT, Mehnert F, Overgaard S, Johnsen SP. Risk factors for venous thromboembolism in patients undergoing total hip replacement and receiving routine thromboprophylaxis. The Journal of Bone and Joint Surgery. American Volume 2010 Sep;92(12):2156-64.
2. Clement ND, Breusch SJ, Biant LC. Lower limb joint replacement in rheumatoid arthritis. Journal of Orthopaedic Surgery and Research 2012 Jun;7:27.
3. Tanaka E, Saito A, Kamitsuji S, Yamada T, Nakajima A, Taniguchi A, Hara M, Tomatsu T, Yamanaka H, Kamatani N. Impact of shoulder, elbow, and knee joint involvement on assessment of rheumatoid arthritis using the American College of Rheumatology core data set. Arthritis & Rheumatism 2005 Dec;53(6):864-71.
4. Danoff JR, Moss G, Liabaud B, Geller JA. Total knee arthroplasty consideration in rheumatoid arthritis. Autoimmune Diseases 2013;2013:185340.
5. Garbarino LJ, Gold PA, Sodhi N, Anis HK, Ehiorobo JO, Boraiah S, Danoff JR, Rasquinha VJ, Higuera-Rueda CA, Mont MA. The effect of operative time on in-hospital length of stay in revision total knee arthroplasty. Annals of Translational Medicine 2019 Feb;7(4):66.
6. Lee JK, Choi СH. Total knee arthroplasty in rheumatoid arthritis. Knee Surgery & Related Research 2012 Mar;24(1):1-6.
7. Grennan DM, Gray J, Loudon J, Fear S. Methotrexate and early postoperative complications in patients with rheumatoid arthritis undergoing elective orthopaedic surgery. Annals of the Rheumatic Diseases 2001 Mar;60(3):214-7.
8. Sreekumar R, Gray J, Kay P, Grennan DM. Methotrexate and post operative complications in patients with rheumatoid arthritis undergoing elective orthopaedic surgery – a ten year follow-up. Acta Orthopaedica Belgica 2011 Dec;77(6):823-6.
9. Eid AS, Mohamed Nassar WA, Mohamed Fayyad TA. Total knee replacement with tibial tubercle osteotomy in rheumatoid patients with stiff knee. International Orthopaedics 2016 Nov;40(11):2289-93.
10. Howe CR, Gardner GC, Kadel NJ. Perioperative medication management for the patient with rheumatoid arthritis. The Journal of the American Academy of Orthopaedic Surgeons 2006 Sep;14(9):544-51.
11. Nasonov EL, Karateyev DE. Use of genetically engineered biological agents for treatment of rheumatoid arthritis: general characteristics. Lecture. Rheumatology Science and Practice 2013;51(2):163-9 (In Russian).
12. Hayashi M, Kojima T, Funahashi K, Kato D, Matsubara H, Shioura T, Kanayama Y, Hirano Y, Ishiguro N. Effect of total arthroplasty combined with anti-tumor necrosis factor agents in attenuating systemic disease activity in patients with rheumatoid arthritis. Modern Rheumatology 2012 Jun;22(3):363-9.
13. Sreekumar R, Gray J, Kay P, Grennan DM. Methotrexat and post operative complication in patients with rheumatoid arthritis undergoing elective orthopedic surgery – a ten-year follow-up. Acta Orthopaedic Belgica 2011 Dec;77(6):823-6.
14. Hayashi M, Kojima T, Funahashi K, Kato D, Matsubara H, Shioura T, Kanayama Y, Hirano Y, Ishiguro N. Effect of total arthroplasty combined with anti-tumor necrosis factor agents in attenuating systemic disease activity in patients with rheumatoid arthritis. Modern Rheumatology 2012 Jun;22(3):363-9.
15. Goodman SM, Springer B, Guyatt G, Abdel MP, Dasa V, George M, Gewurz-Singer O, Giles JT, Johnson B, Lee S, Mandl LA, Mont MA, Sculco P, Sporer S, Stryker L, Turgunbaev M, Brause B, Chen AF, Gililland J, Goodman M, Hurley-Rosenblatt A, Kirou K, Losina E, MacKenzie R, Michaud K, Mikuls T, Russell L, Sah A, Miller AS, Singh JA, Yates A. 2017 American College of Rheumatology/American Association of Hip and Knee Surgeons Guideline for the perioperative management of antirheumatic medication in patients with rheumatic diseases undergoing elective total hip or total knee arthroplasty. Arthritis Care & Research 2017 Aug;69(8):1111-24.
16. Sevitt S. Pathology and pathogenesis of deep vein thrombosis. In: Venous problems. Bergan J, Yao J, editors. Chicago: Year Book Medical Publishers; 1976.
17. Nicolaides A, Kakkar V, Renney J. Solia sinuses and stasis. The British Journal of Surgery 1970 Apr;57(4):307.
18. Nicolaides AN, Kakkar VV, Field ES, Fish P. Venous stasis and deep-vein thrombosis. The British Journal of Surgery 1972 Sep;59(9):713-7.
19. Clark C, Cotton L. Blood flow in deep veins of leg: recording technique and evaluation of method to increase flow during operation. The British Journal of Surgery 1968 Mar;55(3):211-4.
20. Lindström B, Ahlman H, Jonsson O, Stenqvist O. Influence of anaesthesia on blood flow to the calves during surgery. Acta Anaesthesiologica Scandinavica 1984 Apr;28(2):201-3.
21. Lindström B, Ahlman H, Jonsson O, Sivertsson R, Stenqvist O. Blood flow in the calves during surgery. Acta Chirurgica Scandinavica 1977;143(6):335-9.
22. Stamatakis JD, Kakkar VV, Sagar S, Lawrence D, Nairn D, Bentley PG. Femoral vein thrombosis and total hip replacement. BMJ 1977 Jul;2(6081):223-5.
23. Johnson R, Carmichael JH, Almond HG, Loynes RP. Deep venous thrombosis following Charnley arthroplasty. Clinical Orthopaedics and Related Research 1978 May;132:24-30.
24. Planes A, Vochelle N, Fagola M. Total hip replacement and deep vein thrombosis: a venographic and necropsy study. The Journal of Bone & Joint Surgery. British Volume 1990 Jan;72(1):9-13.
25. Gitel SN, Salvati EA, Wessler S, Robinson HJ Jr, Worth MH Jr. The effect of total hip replacement and general surgery on antithrombin III in relation to venous thrombosis. The Journal of Bone and Joint Surgery. American Volume 1979 Jul;61(5):653-6.
26. Eriksson BI, Eriksson E, Gyzander E, Teger-Nilsson AC, Risberg B. Thrombosis after hip replacement. Relationship to the fibrinolytic system. Acta Orthopaedica Scandinavica 1989 Apr;60(2):159-63.
27. Kluft C, Verheijen JH, Jie AF, Rijken DC, Preston FE, Sue-Ling HM, Jespersen J, Aasen AO. The postoperative fibrinolytic shutdown: a rapidly reverting acute phase pattern for the fast-acting inhibitor of tissue-type plasminogen activator after trauma. Scandinavian Journal of Clinical and Laboratory Investigation 1985 Nov;45(7):605-10.
28. D’Angelo A, Kluft C, Verheijen JH, Rijken DC, Mozzi E, Mannucci PM. Fibrinolytic shut-down after surgery: impairment of the balance between tissue-type plasminogen activator and its specific inhibitor. European Journal of Clinical Investigation 1985 Dec;15(6):308-12.
29. Geerts WH, Bergqvist D, Pineo GF, Heit JA, Samama CM, Lassen MR, Colwell CW. Prevention of venous thromboembolism: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition). Chest 2008 Jun;133(6 Suppl):381S-453S.
30. Caprini J. Risk assessment as a guide for the prevention of the many faces of venous thromboembolism. The American Journal of Surgery 2010 Jan;199(1 Suppl):S3-10.
31. Bahl V, Hu HM, Henke PK, Wakefield TW, Campbell DA Jr, Caprini JA. A validation study of a retrospective venous thromboembolism risk scoring method. Annals of Surgery 2010 Feb;251(2):344-50.
32. Association of Phlebologists of Russia; Association of Cardiovascular Surgeons of Russia; Russian Society of Surgeons; Russian Scientific Medical Society of Therapists; Society of Specialists in Emergency Cardiology. Russian clinical guidelines for the diagnosis, treatment and prevention of venous thromboembolic complications. Phlebology. Issue 2 2015;9(4):6-52 (In Russian).
33. Falck-Ytter Y, Francis CW, Johanson NA, Curley C, Dahl OE, Schulman S, Ortel TL, Pauker SG, Colwell CW Jr. Prevention of VTE in orthopedic surgery patients: antithrombotic therapy and prevention of thrombosis. 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 2012 Feb;141(2 Suppl):e278S-325S.
34. Hull RD, Pineo GF, Stein PD, Mah AF, MacIsaac SM, Dahl OE, Butcher M, Brant RF, Ghali WA, Bergqvist D, Raskob GE. Extended out-of-hospital low-molecular-weight heparin prophylaxis against deep venous thrombosis in patients after elective hip arthroplasty: a systematic review. Annals of Internal Medicine 2001 Nov;135(10):858-69.
35. Eikelboom JW, Quinlan DJ, Douketis JD. Extended-duration prophylaxis against venous thromboembolism after total hip or knee replacement: a meta-analysis of the randomized trials. The Lancet 2001 Jul;358(9275):9-15.
36. Prandoni P, Bruchi O, Sabbion P, Tanduo C, Scudeller A, Sardella C, Errigo G, Pietrobelli F, Maso G, Girolami A. Prolonged thromboprophylaxis with oral anticoagulants after total hip arthroplasty: a prospective controlled randomized study. Archives of Internal Medicine 2002 Sep;162(17):1966-71.
37. Kim JS. Deep vein thrombosis prophylaxis after total hip Arthroplasty in Asian patients. Hip & Pelvis 2018 Dec;30(4):197-201.
38. Ettema HB, Hoppener MR, Veeger NJGM, Büller HR, van der Meer J. Low incidence of venographically detected deep vein thrombosis after knee arthroscopy without thromboprophylaxis: a prospective cohort study. Journal of Thrombosis and Haemostasis 2006 Jun;4(6):1411-4.
39. Hoppener MR, Ettema HB, Henny CR, Verheyen CCPM, Büller HR. Low incidence of deep vein thrombosis after knee arthroscopy without thromboprophy-laxis: a prospective cohort study of 335 patients. Acta Orthopoedica 2006 Oct;77(5):767-71.
40. Kahn SR, Shivakumar S. What’s new in VTE risk and prevention in orthopedic surgery. Research and Practice in Thrombosis and Haemostasis 2020 Mar;4(3):366-76.
41. Ilahi OA. Deep venous thrombosis after knee arthroscopy: a meta-analysis. Arthroscopy: the Journal of Arthroscopic & Related Surgery 2005 Jun;21(6):727-30.
42. Camporese G, Bernardi E, Prandoni P, Noventa F, Verlato F, Simioni P, Ntita K, Salmistraro G, Frangos C, Rossi F, Cordova R, Franz F, Zucchetta P, Kontothanassis D, Andreozzi GM; KANT (Knee Arthroscopy Nadroparin Thromboprophylaxis) Study Group. Low-molecular-weight heparin versus compression stockings for thromboprophylaxis after knee arthroscopy: a randomized trial. Annals of Internal Medicine 2008 Jul;149(2):73-82.
43. Wirth T, Schneider B, Misselwitz F, Lomb M, Tüylü H, Egbring R, Griss P. Prevention of venous thromboembolism after knee arthroscopy with low-molecular weight heparin (reviparin): results of a randomized controlled trial. Arthroscopy 2001 Apr;17(4):393-9.
44. Michot M, Conen D, Holtz D, Erni D, Zumstein MD, Ruflin GB, Renner N. Prevention of deep-vein thrombosis in ambulatory arthroscopic knee surgery: a randomized trial of prophylaxis with low-molecular weight heparin. Arthroscopy 2002 Mar;18(3):257-63.
45. Ramos J, Perrotta C, Badariotti G, Berenstein G. Interventions for preventing venous thromboembolism in adults undergoing knee arthroscopy (Review). Cochrane Database of Systematic Reviews 2008 Oct 8;(4):CD005259.
46. Galanis T, Thomson L, Palladino M, Merli G. New oral anticoagulants. Journal of Thrombosis and Thrombolysis 2011 Apr;31(3):310-20.
47. Raghavan N, Frost CE, Yu Z, He K, Zhang H, Humphreys WG, Pinto D, Chen S, Bonacorsi S, Wong PC, Zhang D. Apixaban metabolism and pharmacokinetics after oral administration to humans. Drug Metabolism & Disposition 2009 Jan;37(1):74-81.
48. Lassen MR, Raskob GE, Gallus A, Pineo G, Chen D, Portman RJ. Apixaban or enoxaparin for thromboprophylaxis after knee replacement. The New England Journal of Medicine 2009 Aug;361(6):594-604.
49. Lassen MR, Raskob GE, Gallus A, Pineo G, Chen D, Hornick P; ADVANCE-2 Investigators. Apixaban versus enoxaparin for thromboprophylaxis after knee replacement (ADVANCE-2): a randomised double-blind trial. The Lancet 2010 Mar;375(9717):807-15.
50. Lassen MR, Gallus A, Raskob GE, Pineo G, Chen D, Ramirez LM; ADVANCE-3 Investigators. Apixaban versus enoxaparin for thromboprophylaxis after hip replacement. The New England Journal of Medicine 2010 Dec;363(26):2487-98.
51. Eriksson BI, Borris LC, Friedman RJ, Haas S, Huisman MV, Kakkar AK, Bandel TJ, Beckmann H, Muehlhofer E, Misselwitz F, Geerts W; RECORD1 Study Group. Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplasty. The New England Journal of Medicine 2008 Jun;358(26):2765-75.
52. Lassen MR, Ageno W, Borris LC, Lieberman JR, Rosencher N, Bandel TJ, Misselwitz F, Turpie AG. Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty. The New England Journal of Medicine 2008 Jun;358(26):2776-86.
53. Kakkar AK, Brenner B, Dahl OE, Eriksson ВI, Mouret P, Muntz J, Soglian AG, Pap AF, Misselwitz F, Haas S; RECORD2 Investigators. Extended duration rivaroxaban versus short-term enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty: a double-blind, randomised controlled trial. The Lancet 2008 Jul;372(9632):31-9.
54. Turpie AG, Lassen MR, Davidson BL, Bauer KA, Gent M, Kwong LM, Cushner FD, Lotke PA, Berkowitz SD, Bandel TJ, Benson A, Misselwitz F, Fisher WD; RECORD4 Investigators. Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty (RECORD4): a randomised trial. The Lancet 2009 May;373(9676):1673-80.
55. Eriksson BI, Dahl OE, Rosencher N, Kurth AA, van Dijk CN, Frostick SP, Kalebo P, Christiansen AV, Hantel S, Hettiarachchi R, Schnee J, Büller HR; RE-MODEL Study Group. Oral dabigatran etexilate vs. subcutaneous enoxaparin for the prevention of venous thromboembolism after total knee replacement: the RE-MODEL randomized trial. Journal of Thrombosis and Haemostasis 2007 Nov;5(11):2178-85.
56. Eriksson BI, Dahl OE, Rosencher N, Kurth AA, van Dijk CN, Frostick SP, Prins MH, Hettiarachchi R, Hantel S, Schnee J, Buller HR. Dabigatran etexilate versus enoxaparin for prevention of venous thromboembolism after total hip replacement: a randomised, double-blind, non-inferiority trial. The Lancet 2007 Sep;370(9591):949-56.
57. Eriksson BI, Dahl OE, Huo MH, Kurth AA, Hantel S, Hermansson K, Schnee JM, Friedman RJ; RE-NOVATE II Study Group. Oral dabigatran versus enoxaparin for thromboprophylaxis after primary total hip arthroplasty (RE-NOVATE II*). A randomised, double-blind, non-inferiority trial. Thrombosis and Haemostasis 2011 Apr;105(4):721-9.
58. RE-MOBILIZE Writing Committee; Ginsberg JS, Davidson BL, Comp PC, Francis CW, Friedman RJ, Huo MH, Lieberman JR, Muntz JE, Raskob GE, Clements ML, Hantel S, Schnee JM, Caprini JA. Oral thrombin inhibitor dabigatran etexilate vs North American enoxaparin regimen for prevention of venous thromboembolism after knee arthroplasty surgery. The Journal of Arthroplasty 2009 Jan;24(1):1-9.
59. Venker BT, Ganti BR, Lin H, Lee ED, Nunley RM, Gage BF. Safety and efficacy of new anticoagulants for the prevention of venous thromboembolism after hip and knee arthroplasty: a meta-analysis. The Journal of Arthroplasty 2017 Feb;32(2):645-52.
60. Ferro JM, Coutinho JM, Dentali F, Kobayashi A, Alasheev A, Canhão P, Karpov D, Nagel S, Posthuma L, Roriz JM, Caria J, Frässdorf M, Huisman H, Reilly P, Diener HC; RE-SPECT CVT Study Group. Safety and efficacy of dabigatran etexilate vs dose-adjusted warfarin in patients with cerebral venous thrombosis: a randomized clinical trial. JAMA Neurology 2019 Dec;76(12):1457-65.
61. Samoš M, Stančiaková L, Ivanková J, Staško J, Kovář F, Dobrotová M, Galajda P, Kubisz P, Mokáň M. Monitoring of dabigatran therapy using Hemoclot(®) Thrombin Inhibitor assay in patients with atrial fibrillation. Journal of Thrombosis and Thrombolysis 2015 Jan;39(1):95-100.
62. Poli S, Härtig F, Spencer C, Ebner M, Birschmann I, Kuhn J, Faix S, Ziemann U, Häring HU, Lehmann R, Peter A, Hörber S. Diagnostic accuracy of a novel chromogenic direct thrombin inhibitor assay: clinical experiences for dabigatran monitoring. Thrombosis and Haemostasis 2017 Dec;117(12):2369-75.
63. Cohen AT, Hamilton M, Mitchell SA, Phatak H, Liu X, Bird A, Tushabe D, Batson S. Comparison of the novel oral anticoagulants apixaban, dabigatran, edoxaban, and rivaroxaban in the initial and long-term treatment and prevention of venous thromboembolism: systematic review and network meta-analysis. PLoS One 2015 Dec;10(12):e0144856.
  

[ Содержание выпуска N 3 | Выпуски журнала | Список журналов ]